Jubilant Therapeutics is a patient-focused biopharmaceutical company advancing potent and selective small molecule modulators to address specific unmet medical needs in oncology and autoimmune diseases. The company’s leadership and scientific team are science-driven executives with global pharma background and experience in advancing innovative drug candidates into the clinic. Jubilant Therapeutics is headquartered in the U.S. with independent board and management, guided by globally renowned KOLs and SAB.
Key Therapeutic Areas
• Oncology
• Auto-immune Disorders
Portfolio
• Novel PAD4 inhibitors targeting auto-immune disorders
• Dual LSD1/HDAC6 inhibitors targeting cancer
• Novel small molecule PD-L1 inhibitors
• Novel brain penetrating PRMT5 inhibitors targeting cancer
Company Details
- Employees
- 13
- Founded
- -
- Address
- 790, Township Line Road, Suite 175, Yardley,pennsylvania 19067,united States
- Industry
- Biotechnology
- Website
- http://www.jubilanttx.com
- HQ
- Yardley, Pennsylvania
Jubilant Therapeutics Inc Questions
Jubilant Therapeutics Inc's website is http://www.jubilanttx.com
Jubilant Therapeutics Inc's LinkedIn profile is https://www.linkedin.com/company/jubilant-therapeutics
Jubilant Therapeutics Inc has
13 employees.
View email and phone details for 13
employees at Jubilant Therapeutics Inc.
Jubilant Therapeutics Inc's industry is
Biotechnology
Jubilant Therapeutics Inc's top competitors are
Jubilant Foodworks Ltd.,
Jubilant Ingrevia Limited,
Jubilant Radiopharma,
Jubilant Chemsys -> Jubilant Biosys Limited,
Intas Pharmaceuticals,
Jubilant Hollisterstier Cmo,
Jubilant Pharmova Limited,
Jubilant Biosys Limited,
Cipla,
Jubilant Generics Limited.
Jubilant Therapeutics Inc's categories are Biotechnology
Jubilant Therapeutics Inc's founding year is 2019
